MedTrace Logo

Safety and Efficacy of Chloroquine Associated With Dehydroepiandrosterone Sulphate to Treat Uncomplicated Falciparum Malaria

NCT00442403 · Status: SUSPENDED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2007-03-01

No results posted yet for this study

Summary

This study aims to evaluate the safety and efficacy of a standard chloroquine drug regimen administration supplemented with dehydroepiandrosterone sulfate against drug-resistant malaria.

Conditions

Interventions

DRUG

chloroquine

DRUG

dehydroepiandrosterone sulphate

Sponsors & Collaborators

  • Université Victor Segalen Bordeaux 2

    lead OTHER

Principal Investigators

  • Michel LE BRAS, Professor · Université Victor Segalen Bordeaux 2, Centre René Labusquière (Santé et Développement)

  • Pascal MILLET, Doctor · Université Victor Segalen Bordeaux 2, Pôle des Maladies Tropicale, CHU de Bordeaux

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-04-30
Completion
2002-09-30

Countries

  • Cameroon

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00442403 on ClinicalTrials.gov